DrugScreens.com Names Molly McClure Fractional CMO to Lead Next Phase of Growth

Marketing executive who helped build DrugScreens.com brand from the ground up returns as the investor-backed company prepares for its next stage of expansion

SAN ANTONIO, TX, UNITED STATES, August 24, 2026 /EINPresswire.com/ — DrugScreens.com, an investor-backed national provider of professional drug screening supplies, today announced the appointment of Molly McClure⁠ as Fractional Chief Marketing Officer, bringing back one of the original architects behind the company’s brand as it enters a pivotal stage of growth.

McClure’s history with DrugScreens.com began before the company officially launched. Working alongside the founding team, she led the early development of the brand, including its positioning, messaging, visual identity, website strategy and build, go-to-market foundation and digital presence.

Now, she returns in an expanded leadership capacity to help scale what she helped create.

“Molly has been part of the DNA of DrugScreens.com since before we went live,” said Corbin Smith, investor and advisor to DrugScreens.com. “She understood early that we weren’t simply building another e-commerce site. We were building a trusted resource for organizations responsible for workplace safety, treatment, compliance and drug screening programs. Bringing her back as our Fractional CMO is a natural next step as we accelerate our growth.”

The work carries real-world consequences. Drug screening sits at the intersection of workplace safety, public safety, recovery and organizational risk. For employers, treatment providers, healthcare organizations and other testing programs, access to the right screening tools can help organizations make informed decisions, maintain safer environments and support consistent testing programs.

As the drug landscape continues to evolve, so does the need for clear information and reliable access to appropriate screening solutions. That responsibility is central to how DrugScreens.com approaches growth.

As Fractional CMO, McClure will oversee brand and growth strategy, demand generation, e-commerce, content and SEO, customer acquisition, market expansion and the continued evolution of the DrugScreens.com customer experience.

McClure brings a growth mindset, fierce customer focus and a strong instinct for storytelling to the role. Throughout her career, she has worked with powerhouse brands operating in highly regulated industries, building and leading marketing strategies where customer trust, compliance and clarity are critical.

Her approach connects brand strategy to measurable business outcomes: understand the customer first, identify opportunities for growth and translate complex products and markets into clear, compelling stories that move people to action.

“There is something incredibly rewarding about coming back to a company you helped build before the first customer ever placed an order,” said McClure. “Drug screening isn’t just a product category. Behind every order is an organization trying to protect its people, support recovery, manage risk or create a safer environment. Our opportunity is to make that process easier to understand and easier to navigate.”

The appointment comes at an important inflection point for DrugScreens.com. With investor backing and an expanding national customer base, the company is investing in the leadership, technology and marketing capabilities needed to support its next phase of growth.

DrugScreens.com continues to expand its portfolio across urine, oral fluid and other drug screening solutions while serving employers, staffing organizations, treatment and recovery programs, healthcare organizations, government entities and other professional testing environments.

“The next chapter requires us to be very intentional about where we invest, who we serve and how we differentiate,” McClure added. “Growth matters, but so does how you get there. If we stay fiercely focused on the customer, tell better stories and make a complicated industry easier to navigate, the growth follows.”

About DrugScreens.com

DrugScreens.com is an investor-backed, U.S.-based provider of professional drug screening supplies serving organizations across workplace testing, staffing, healthcare, treatment and recovery, corrections and other professional testing environments.

The company offers a growing portfolio of urine and oral-fluid drug screening products from established manufacturers, with an emphasis on product education, responsive service and a simplified purchasing experience.

+1 800-652-3502
support@drugscreens.com
Media Team
DrugScreens.com
Visit us on social media:
LinkedIn

Media gallery